Protalix BioTherapeutics
PLX
PLX
33 hedge funds and large institutions have $21.2M invested in Protalix BioTherapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $27K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$27K
Top Buyers
| 1 | +$40.1K | |
| 2 | +$28.5K | |
| 3 | +$13K | |
| 4 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.46K |
Top Sellers
| 1 | -$265K | |
| 2 | -$104K | |
| 3 | -$101K | |
| 4 |
Jane Street
New York
|
-$87.8K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$46.9K |